BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2000220)

  • 1. Determinants of sequence-specific DNA-binding by p48v-myb.
    Garcia A; LaMontagne K; Reavis D; Stober-Grässer U; Lipsick JS
    Oncogene; 1991 Feb; 6(2):265-73. PubMed ID: 2000220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly conserved cysteine in the v-Myb DNA-binding domain is essential for transformation and transcriptional trans-activation.
    Grässer FA; LaMontagne K; Whittaker L; Stohr S; Lipsick JS
    Oncogene; 1992 May; 7(5):1005-9. PubMed ID: 1570148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-sensitive DNA binding by v-myb and c-myb proteins.
    Klempnauer KH
    Oncogene; 1993 Jan; 8(1):111-5. PubMed ID: 8423989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral myb oncogene encodes a sequence-specific DNA-binding activity.
    Biedenkapp H; Borgmeyer U; Sippel AE; Klempnauer KH
    Nature; 1988 Oct; 335(6193):835-7. PubMed ID: 3185713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single amino-acid substitution in the DNA-binding domain of the myb oncogene confers a thermolabile phenotype to E26-transformed myeloid cells.
    Li RP; Duterque-Coquillaud M; Lagrou C; Debuire B; Graf T; Stehelin D; Leprince D
    Oncogene Res; 1989; 5(2):137-41. PubMed ID: 2608278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes differentially expressed in two types of v-myb-transformed avian myelomonocytic cells.
    Nakano T; Graf T
    Oncogene; 1992 Mar; 7(3):527-34. PubMed ID: 1549365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human A-myb protein is a strong activator of transcription.
    Golay J; Loffarelli L; Luppi M; Castellano M; Introna M
    Oncogene; 1994 Sep; 9(9):2469-79. PubMed ID: 8058310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of transcriptional activation and oncogenic transformation by v-Myb.
    Chen RH; Fields S; Lipsick JS
    Oncogene; 1995 Nov; 11(9):1771-9. PubMed ID: 7478605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. trans activation of gene expression by v-myb.
    Ibanez CE; Lipsick JS
    Mol Cell Biol; 1990 May; 10(5):2285-93. PubMed ID: 2325652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro.
    Aziz N; Wu J; Dubendorff JW; Lipsick JS; Sturgill TW; Bender TP
    Oncogene; 1993 Aug; 8(8):2259-65. PubMed ID: 8336948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of c-Myb through protein phosphorylation and leucine zipper interactions.
    Ramsay RG; Morrice N; Van Eeden P; Kanagasundaram V; Nomura T; De Blaquiere J; Ishii S; Wettenhall R
    Oncogene; 1995 Nov; 11(10):2113-20. PubMed ID: 7478531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR structure of the hRap1 Myb motif reveals a canonical three-helix bundle lacking the positive surface charge typical of Myb DNA-binding domains.
    Hanaoka S; Nagadoi A; Yoshimura S; Aimoto S; Li B; de Lange T; Nishimura Y
    J Mol Biol; 2001 Sep; 312(1):167-75. PubMed ID: 11545594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
    Foos G; Natour S; Klempnauer KH
    Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of a small phosphopeptide at the carboxyterminus of the viral myb protein by monoclonal antibodies.
    Bading H; Beutler C; Moelling K
    Oncogene; 1989 Jan; 4(1):33-8. PubMed ID: 2464784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
    Hahn SL; Wasylyk B
    Oncogene; 1994 Sep; 9(9):2499-512. PubMed ID: 8058313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein.
    Bartůnek P; Karafiát V; Dvoráková M; Záhorová V; Mandíková S; Zenke M; Dvorák M
    Oncogene; 1997 Dec; 15(24):2939-49. PubMed ID: 9416837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.